![Rebecca Chambers](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rebecca Chambers
Directeur Financier/CFO chez
VERACYTE, INC.
Fortune : 10 M $ au 30/06/2026
Profil
Rebecca Chambers is currently Chief Financial Officer at Veracyte, Inc. since 2021.
Former roles include Independent Director at Inari Medical, Inc. from 2021 to 2025, Chief Financial Officer at Outset Medical, Inc. from 2019 to 2021, Director-Investor Relations & Communications at Myriad Genetics, Inc. from 2011 to 2012, Senior Manager-Investor Relations at Life Technologies Corp.
from 2009 to 2010, Senior Research Associate at Millennium Pharmaceuticals, Inc. from 1999 to 2003, Vice President at Bank of America Corp., VP-Finance, Investor Relations & Treasury at Illumina, Inc., Director at Alamar Biosciences, Inc. Education includes undergraduate studies at John Carroll University and an MBA from Johnson Graduate School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VERACYTE, INC. 0,22 % | 04/06/2026 | 173 280 ( 0,22 % ) | 10 M $ | 30/06/2026 |
Postes actifs de Rebecca Chambers
| Sociétés | Poste | Début |
|---|---|---|
| VERACYTE, INC. | Directeur Financier/CFO | 19/07/2021 |
Anciens postes connus de Rebecca Chambers
| Sociétés | Poste | Fin |
|---|---|---|
| INARI MEDICAL, INC. | Directeur/Membre du Conseil | 19/02/2025 |
| OUTSET MEDICAL, INC. | Directeur Financier/CFO | 16/07/2021 |
| MYRIAD GENETICS, INC. | Investor Relations Contact | 01/10/2012 |
Life Technologies Corp.
 Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Public Communications Contact | 01/12/2010 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01/01/2003 |
Formation de Rebecca Chambers
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
77
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Bank of America Corp.
 Bank of America Corp. Major BanksFinance Operates as a bank holding company whose subsidiaries provides consumer and global banking, markets brokerage & wealth and investment management services | Finance |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Myriad Genetics, Inc.
 Myriad Genetics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic and predictive medicine products | Health Technology |
Illumina, Inc.
 Illumina, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that develops laboratory instruments | Health Technology |
Veracyte, Inc.
 Veracyte, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes diagnostic products & biopharmaceutical services | Health Technology |
Outset Medical, Inc.
 Outset Medical, Inc. Medical SpecialtiesHealth Technology Operates as a pioneering medical technology company which develops and commercializes reimagining dialysis for patients & health care providers | Health Technology |
Alamar Biosciences, Inc.
 Alamar Biosciences, Inc. Medical SpecialtiesHealth Technology In vitro diagnostics | Health Technology |
John Carroll University
 John Carroll University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johnson Graduate School of Management
 Johnson Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Life Technologies Corp.
Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Inari Medical, Inc.
 Inari Medical, Inc. Medical SpecialtiesHealth Technology Develops catheter-based mechanical thrombectomy devices | Health Technology |
Choisissez Zonebourse 
